KYMERA THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2026-03-31 · SEC EDGAR
FY2026 - Q4(Jan 26 · Feb 26 · Mar 26)
Total Assets
$1.67B
↑+81.7% +$751Mvs FY2025
Total Liabilities
$129M
↓-2.0% -$3Mvs FY2025
Equity
$1.54B
↑+95.8% +$753Mvs FY2025
Cash
$144M
↑+60.2% +$54Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $1.67B | $918M |
| Current Assets | $677M | $501M |
| Cash | $144M | $90M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $533M | $411M |
| Non-Current Assets | $992M | $417M |
| PPE | $42M | $49M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $950M | $368M |
| Total Liab+Eq | $1.67B | $918M |
| Current Liab. | $63M | $59M |
| Accounts Payable | $13M | $10M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $11M |
| Other CL | $50M | $37M |
| Non-Current Liab. | $67M | $73M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $67M | $73M |
| Equity | $1.54B | $786M |
| Retained Earnings | $1.14B | $820M |
| Other Equity | $404M | $0 |
QuarterCharts · SEC EDGAR data · KYMR · Comparing FY2026 vs FY2025